Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma in hospitalized Veterans with COVID-19
NCT04539275Phase 3Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Biologic
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Convalescent Plasma with Masked Saline Placebo (2 arms). Primary endpoint: Proportion of Participants Developing Acute Hypoxemic Respiratory Failure or All-cause Death at 28 days. Started Nov 2020; status: terminated.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04539275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04539275.